Abeona Therapeutics Inc (FRA:PCJ)
€ 5.9 0 (0%) Market Cap: 256.81 Mil Enterprise Value: 164.59 Mil PE Ratio: 0 PB Ratio: 3.64 GF Score: 42/100

Q4 2022 Abeona Therapeutics Inc Earnings Call Transcript

Mar 29, 2023 / 12:30PM GMT
Release Date Price: €2.52 (+2.44%)
Operator

Good morning, everybody, and welcome to the Abeona Fourth Quarter and Fiscal Year 2022 Earnings Conference Call.

(Operator Instructions)

Please note, this conference is being recorded. I will now turn the conference over to your host, Mr. Greg Gin, Vice President of Investor Relations and Corporate Communications at Abeona. Greg, over to you.

Gregory Gin
Abeona Therapeutics Inc. - VP of IR & Corporate Communications

Thank you, Jenny. Good morning, everyone. I would like to welcome and thank everyone for joining us on our fourth quarter and full year 2022 conference call.

The press release announcing the results is available on our website at www.abeonatherapeutics.com. On the call today with prepared remarks are Vish Seshadri, Chief Executive Officer of Abeona; and Joe Vazzano, Chief Financial Officer. After the prepared remarks, we will host a Q&A session.

For that session, we're also joined by Dr. Brian Kevany, Chief Technical Officer and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot